References
- Desloge RB, Carew JF, Finstad CL, et al. DNA analy�sis of human cholesteatomas. Am J Otol 1997; 18: 155–9.
- Levenson MJ, Michaels L, Parisier SC. Congenital cholesteatomas of the middle ear in children: origin and management. Otolaryngol Clin North Am 1989; 22: 941–53.
- Kojima H, Miyazaki H, Tanaka Y, Shiwa M, Koga T. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium. Arch Otolaryngol Head Neck Surg 1999; 125: 738–42.
- Albino P, Kimmelman CP, Parisier SC. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998; 19: 7 19.
- Acar H, Caliskan U, Demirel S, Largaespada DA. Micronucleus incidence and their chromosomal origin related to therapy in acute lymphoblastic leukemia (ALL) patients: detection by micronucleus and FISH techniques. Teratog Carcinog Mutagen 2001; 21: 341 � 7.
- Chole RA, Faddis BT, Chamberlain S, Magilke D. Invasiveness of fibroblasts from experimental cholesteatomas. Otol Neurotol 2001; 22: 15–7.
- Heim S, Mitelman F. Cancer cytogenetics. New York: Wiley-Liss, 1994: 1 24.
- Erbersdobler A, Kaiser H, Friedrich MG, Henke RP. Numerical aberrations of chromosome 8 and allelic loss at 8p in non-muscle-invasive urothelial carcinomas of the urinary bladder. Eur Urol 2000; 38: 590–6.
- Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Richardson MA, Schuller DE. Chronic otitis me�dia, mastoiditis, and petrositis. In: Chole RA, Choo MJ, eds. Otolaryngology head neck surgery. St. Louis, MO: Mosby, 1998: 3026–46.
- Lavezzi A, Mantovani M, Cazzullo A, Turconi P. Significance of trisomy 7 related to PCNA index in cholesteatoma. Am J Otolaryngol 1998; 19: 109 12.
- Erg�n S, Zheng Xi, Carls�� B. Expression of trans�forming growth factor-a and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol 1996; 17: 393–6.
- Kuijpers W, Vennix PPCA, Peters TA, Ramaekers FCS. Squamous metaplasia of the middle ear epithe�lium. Acta Otolaryngol (Stockh) 1996; 116: 293–8.
- Goh EK, Lee BJ, Wang SG, Chon KM, Kim CM. Expression of telomerase activity in cholesteatoma oti�tis media. J Laryngol Otol 2001; 115: 881–4.
- Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Moriyama H. Molecular biological diagnosis of con�genital and acquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 2001; 111: 867–73.
- Pinkel D, Staraume P, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hy-bridization. Proc Natl Acad Sci U S A 1986; 83: 2934–8.
- Acar H, Yildinm MS, Kaynak M. Reliability and efficiency of interphase-FISH with a-satellite probe for detection. Genet Couns 2002; 13: 11–7.
- El-Naggar AK, Dinh M, Tucker SL, Gillenwater A, Luna MA, Batsakis JG. Chromosomal and DNA ploidy characterization of salivary gland neoplasms by combined FISH and flow cytometry. Hum Pathol 1997; 28: 881–6.
- Bettio D, Rizzi N, Giardino D, et al. Cytogenetic study of pituitary adenomas. Cancer Genet Cytogenet 1997; 98: 131–6.
- Han K, Lee W, Harris CP, et al. Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH on archival tissues. Can�cer Genet Cytogenet 1994; 74: 19–24.
- Holly A, Sittinger M, Bujia J. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1995; 252: 366 9.
- Rummukainen JK, Salminen T, Lundin J, Joensuu H, Isola JJ. Amplification of c-myc oncogene by chro-mogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples. Lab Invest 2001; 81: 1545 51.